{"id":"W3170024542","doi":"10.1200/jco.2021.39.15_suppl.8503","title":"Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Clinical endpoint; Lung cancer; Oncology; Chemotherapy; Neoadjuvant therapy; Adverse effect; Randomized controlled trial; Surgery; Cancer; Immunotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00168266,0.0006942783,0.0009501821,0.0002456347,0.0002988051,0.0007533769,0.0005039902,0.0009062717,0.004087848],"category_scores_gemma":[0.001460317,0.0001933564,0.001840631,0.0002537424,0.0004264806,0.0004629033,0.0003756944,0.001817147,0.000380217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006236932,"about_ca_system_score_gemma":0.0006870214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006153334,"about_ca_topic_score_gemma":0.002199485,"domain_scores_codex":[0.9994961,0.0003187838,0.00002561572,0.00006335255,0.000046844,0.00004924796],"domain_scores_gemma":[0.9990492,0.0002444054,0.000316955,0.00006661133,0.00004037555,0.0002824123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9533138,0.004739376,0.00464361,0.001148663,0.001717566,0.00005843194,0.00006612271,0.00124019,0.003223045,0.0001735326,0.004131891,0.02554373],"study_design_scores_gemma":[0.808013,0.153609,0.02871885,0.0001736585,0.002834749,0.0002023791,0.00007462328,0.001710833,0.001362165,0.0004863421,0.002769955,0.00004432437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901453,0.004114958,0.0002612237,0.0005864389,0.0002374788,0.0007766215,0.001716832,0.00003670349,0.002124445],"genre_scores_gemma":[0.9896053,0.001497745,0.0005583718,0.001293915,0.0003004219,0.001202311,0.003717229,0.00001975661,0.00180491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004087848,"threshold_uncertainty_score":0.01367515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07011551329818771,"score_gpt":0.4443878089146798,"score_spread":0.3742722956164921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}